Oxytocin administration attenuates atherosclerosis and inflammation in Watanabe Heritable Hyperlipidemic rabbits

Psychoneuroendocrinology

Volumn 38, Issue 5, 2013, Pages 685-693

  Szeto, Angela ^a   Rossetti, Maria A ^a   Mendez, Armando J ^b   Noller, Crystal M ^a   Herderick, Edward E ^c   Gonzales, Julie A ^a   Schneiderman, Neil ^a   McCabe, Philip M ^a  

^a Department of Biology   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c eehscience LLC   (United States)

Author keywords

Atherosclerosis; C reactive protein; Inflammation; Oxytocin; WHHL rabbit

Indexed keywords

8 ISOPROSTANE; ADIPOCYTOKINE; ADIPONECTIN; C REACTIVE PROTEIN; CYTOKINE; GLUCOSE; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; OXYTOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; ARTICLE; BLOOD SAMPLING; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; CYTOKINE GENE; DIET RESTRICTION; DISEASE ASSOCIATION; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG RESPONSE; GENE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; HYPERLIPIDEMIA; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MALE; NONHUMAN; OSMOTIC PUMP; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RABBIT; URINALYSIS;

ADIPOSE TISSUE; ANIMALS; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; DISEASE MODELS, ANIMAL; INFLAMMATION; INFUSION PUMPS; INSULIN; LIPIDS; MALE; OXYTOCIN; RABBITS; STRESS, PHYSIOLOGICAL; VALIDATION STUDIES AS TOPIC;

EID: 84876090828     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2012.08.009     Document Type: Article

References (69)

1. Agrawal A., Hammond D.J., Singh S.K. Atherosclerosis-related functions of C-reactive protein. Cardiovasc. Hematol. Disord. Drug Targets 2010, 10:235-240.
2. Ahmed M.A., Elosaily G.M. Role of Oxytocin in deceleration of early atherosclerotic inflammatory processes in adult male rats. Int. J. Clin. Exp. Med. 2011, 4:169-178.
3. Ait-Oufella H., Taleb S., Mallat Z., Tedgui A. Recent advances on the role of cytokines in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2011, 31:969-979.
4. Allende-Vigo M.Z. Pathophysiologic mechanisms linking adipose tissue and cardiometabolic risk. Endocr. Pract.: Off. J. Am. Coll. Endocrinol. Am. Assoc. Clin. Endocrinol. 2010, 16:692-698.
5. Altintas M.M., Rossetti M.A., Nayer B., Puig A., Zagallo P., Ortega L.M., Johnson K.B., McNamara G., Reiser J., Mendez A.J., Nayer A. Apoptosis, mastocytosis, and diminished adipocytokine gene expression accompany reduced epididymal fat mass in long-standing diet-induced obese mice. Lipids Health Dis. 2011, 10:198.
6. Berkman L.F., Orth-Gomer K. Prevention of cardiovascular morbidity and mortality: role of social relations. Behavioral Medicine Approaches to Cardiovascular Disease Prevention 1996, 51-67. Erlbaum, Mahwah, NJ. K. Orth-Gomer, N. Schneiderman (Eds.).
7. Bernberg E., Andersson I.J., Gan L.M., Naylor A.S., Johansson M.E., Bergstrom G. Effects of social isolation and environmental enrichment on atherosclerosis in ApoE-/- mice. Stress 2008, 11:381-389.
8. Bobbioni-Harsch E., Frutiger S., Hughes G., Panico M., Etienne A., Zappacosta F., Morris H.R., Jeanrenaud B. Physiological concentrations of oxytocin powerfully stimulate insulin secretionin vitro. Endocrine 1995, 3:55-59.
9. Bonne D., Cohen P. Characterization of oxytocin receptors on isolated rat fat cells. Eur. J. Biochem. 1975, 56:295-303.
10. Buja L.M., Kita T., Goldstein J.L., Watanabe Y., Brown M.S. Cellular pathology of progressive atherosclerosis in the WHHL rabbit. An animal model of familial hypercholesterolemia. Arteriosclerosis 1983, 3:87-101.
11. Carter C.S., Grippo A.J., Pournajafi-Nazarloo H., Ruscio M.G., Porges S.W. Oxytocin, vasopressin and sociality. Prog. Brain Res. 2008, 170:331-336.
12. Cassoni P., Sapino A., Marrocco T., Chini B., Bussolati G. Oxytocin and oxytocin receptors in cancer cells and proliferation. J. Neuroendocrinol. 2004, 16:362-364.
13. Churchland P.S., Winkielman P. Modulating social behavior with oxytoc: how does it work? What does it mean?. Horm. Behav. 2012, 61:392-399.
14. Clarkson T.B., Kaplan J.R., Adams M.R., Manuck S.B. Psychosocial influences on the pathogenesis of atherosclerosis among nonhuman primates. Circulation 1987, 76:I29-I40.
15. DeClercq V., Taylor C., Zahradka P. Adipose tissue: the link between obesity and cardiovascular disease. Cardiovasc. Hematol. Disord. Drug Targets 2008, 8:228-237.
16. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J. Aller. Clin. Immunol. 2005, 115:911-919. quiz 920.
17. Fekete E.M., Antoni M.H., Lopez C., Mendez A.J., Szeto A., Fletcher M.A., Klimas N., Kumar M., Schneiderman N. Stress buffering effects of oxytocin on HIV status in low-income ethnic minority women. Psychoneuroendocrinology 2011, 36:881-890.
18. Florian M., Jankowski M., Gutkowska J. Oxytocin increases glucose uptake in neonatal rat cardiomyocytes. Endocrinology 2010, 151:482-491.
19. Gimpl G., Fahrenholz F. The oxytocin receptor system: structure, function, and regulation. Physiol. Rev. 2001, 81:629-683.
20. Grewen K.M., Girdler S.S., Amico J., Light K.C. Effects of partner support on resting oxytocin, cortisol, norepinephrine, and blood pressure before and after warm partner contact. Psychosom. Med. 2005, 67:531-538.
21. Gutkowska J., Jankowski M., Lambert C., Mukaddam-Daher S., Zingg H.H., McCann S.M. Oxytocin releases atrial natriuretic peptide by combining with oxytocin receptors in the heart. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:11704-11709.
22. Hajer G.R., van Haeften T.W., Visseren F.L. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur. Heart J. 2008, 29:2959-2971.
23. Holt-Lunstad J., Birmingham W.A., Light K.C. Influence of a " warm touch" support enhancement intervention among married couples on ambulatory blood pressure, oxytocin, alpha amylase, and cortisol. Psychosom. Med. 2008, 70:976-985.
24. Jankowski M., Hajjar F., Kawas S.A., Mukaddam-Daher S., Hoffman G., McCann S.M., Gutkowska J. Rat heart: a site of oxytocin production and action. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:14558-14563.
25. Jankowski M., Wang D., Hajjar F., Mukaddam-Daher S., McCann S.M., Gutkowska J. Oxytocin and its receptors are synthesized in the rat vasculature. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:6207-6211.
26. Jankowski M., Bissonauth V., Gao L., Gangal M., Wang D., Danalache B., Wang Y., Stoyanova E., Cloutier G., Blaise G., Gutkowska J. Anti-inflammatory effect of oxytocin in rat myocardial infarction. Basic Res. Cardiol. 2010, 105:205-218.
27. Kaplan J.R., Chen H., Manuck S.B. The relationship between social status and atherosclerosis in male and female monkeys as revealed by meta-analysis. Am. J. Primatol. 2009, 71:732-741.
28. Kaplan J.R., Manuck S.B., Clarkson T.B., Lusso F.M., Taub D.M. Social status, environment, and atherosclerosis in cynomolgus monkeys. Arteriosclerosis 1982, 2:359-368.
29. Karra R., Vemullapalli S., Dong C., Herderick E.E., Song X., Slosek K., Nevins J.R., West M., Goldschmidt-Clermont P.J., Seo D. Molecular evidence for arterial repair in atherosclerosis. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:16789-16794.
30. Kiss A., Mikkelsen J.D. Oxytocin - anatomy and functional assignments: a minireview. Endocr. Regul. 2005, 39:97-105.
31. Knox S.S., Uvnas-Moberg K. Social isolation and cardiovascular disease: an atherosclerotic pathway?. Psychoneuroendocrinology 1998, 23:877-890.
32. Kobayashi H., Yasuda S., Bao N., Iwasa M., Kawamura I., Yamada Y., Yamaki T., Sumi S., Ushikoshi H., Nishigaki K., Takemura G., Fujiwara T., Fujiwara H., Minatoguchi S. Postinfarct treatment with oxytocin improves cardiac function and remodeling via activating cell-survival signals and angiogenesis. J. Cardiovasc. Pharmacol. 2009, 54:510-519.
33. Lee B., Yang C., Chen T.H., al-Azawi N., Hsu W.H. Effect of AVP and oxytocin on insulin release: involvement of V1b receptors. Am. J. Physiol. 1995, 269:E1095-E1100.
34. Light K.C., Grewen K.M., Amico J.A. More frequent partner hugs and higher oxytocin levels are linked to lower blood pressure and heart rate in premenopausal women. Biol. Psychol. 2005, 69:5-21.
35. Maier T., Dai W.J., Csikos T., Jirikowski G.F., Unger T., Culman J. Oxytocin pathways mediate the cardiovascular and behavioral responses to substance P in the rat brain. Hypertension 1998, 31:480-486.
36. Manuck S.B., Marsland A.L., Kaplan J.R., Williams J.K. The pathogenicity of behavior and its neuroendocrine mediation: an example from coronary artery disease. Psychosom. Med. 1995, 57:275-283.
37. McCabe P.M., Gonzales J.A., Zaias J., Szeto A., Kumar M., Herron A.J., Schneiderman N. Social environment influences the progression of atherosclerosis in the watanabe heritable hyperlipidemic rabbit. Circulation 2002, 105:354-359.
38. McCall C., Singer T. The animal and human neuroendocrinology of social cognition, motivation and behavior. Nat. Neurosci. 2012, 15:681-688.
39. Mullenix P.S., Andersen C.A., Starnes B.W. Atherosclerosis as inflammation. Ann. Vasc. Surg. 2005, 19:130-138.
40. Nakashima Y., Plump A.S., Raines E.W., Breslow J.L., Ross R. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler. Thromb.: J. Vasc. Biol. Am. Heart Assoc. 1994, 14:133-140.
41. Nation D.A., Gonzales J.A., Mendez A.J., Zaias J., Szeto A., Brooks L.G., Paredes J., D'Angola A., Schneiderman N., McCabe P.M. The effect of social environment on markers of vascular oxidative stress and inflammation in the Watanabe heritable hyperlipidemic rabbit. Psychosom. Med. 2008, 70:269-275.
42. Nation D.A., Szeto A., Mendez A.J., Brooks L.G., Zaias J., Herderick E.E., Gonzales J., Noller C.M., Schneiderman N., McCabe P.M. Oxytocin attenuates atherosclerosis and adipose tissue inflammation in socially isolated ApoE-/- mice. Psychosom. Med. 2010, 72:376-382.
43. Neumann I.D., Kromer S.A., Toschi N., Ebner K. Brain oxytocin inhibits the (re)activity of the hypothalamo-pituitary-adrenal axis in male rats: involvement of hypothalamic and limbic brain regions. Regul. Pept. 2000, 96:31-38.
44. Ohman M.K., Shen Y., Obimba C.I., Wright A.P., Warnock M., Lawrence D.A., Eitzman D.T. Visceral adipose tissue inflammation accelerates atherosclerosis in apolipoprotein E-deficient mice. Circulation 2008, 117:798-805.
45. Paredes J., Szeto A., Levine J.E., Zaias J., Gonzales J.A., Mendez A.J., Llabre M.M., Schneiderman N., McCabe P.M. Social experience influences hypothalamic oxytocin in the WHHL rabbit. Psychoneuroendocrinology 2006, 31:1062-1075.
46. Petersson M., Alster P., Lundeberg T., Uvnas-Moberg K. Oxytocin causes a long-term decrease of blood pressure in female and male rats. Physiol. Behav. 1996, 60:1311-1315.
47. Petersson M., Eklund M., Uvnas-Moberg K. Oxytocin decreases corticosterone and nociception and increases motor activity in OVX rats. Maturitas 2005, 51:426-433.
48. Petersson M., Hulting A.-L., Uvnas-Moberg K. Oxytocin causes a sustained decrease in plasma levels of corticosterone in rats. Neurosci. Lett. 1999, 264:41-44.
49. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001, 29:e45.
50. Pittman J.A., Boshell B.R., Williams B.H., Hamner D., Hill P. Insulin-like activity of vasopressin and oxytocin. Biochem. Biophys. Res. Commun. 1961, 6:29-32.
51. Reaven G.M. Insulin resistance: the link between obesity and cardiovascular disease. Med. Clin. North Am. 2011, 95:875-892.
52. Ross H.E., Young L.J. Oxytocin and the neural mechanisms regulating social cognition and affiliative behavior. Front. Neuroendocrinol. 2009, 30:534-547.
53. Ross R. Atherosclerosis - an inflammatory disease. N. Engl. J. Med. 1999, 340:115-126.
54. Schneiderman N., Skyler J.S. Insulin metabolism, sympathetic nervous system regulation, and coronary heart disease prevention. Behavioral Medicine Approaches to Cardiovascular Disease Prevention 1996, 105-133. Erlbaum, Mahwah, NJ. K. Orth-Gomer, N. Schneiderman (Eds.).
55. Shively C.A., Clarkson T.B., Kaplan J.R. Social deprivation and coronary artery atherosclerosis in female cynomolgus monkeys. Atherosclerosis 1989, 77:69-76.
56. Smith A.S., Wang Z. Salubrious effects of oxytocin on social stress-induced deficits. Horm. Behav. 2012, 61:320-330.
57. Strunecka A., Hynie S., Klenerova V. Role of oxytocin/oxytocin receptor system in regulation of cell growth and neoplastic processes. Folia Biol. (Praha) 2009, 55:159-165.
58. Syme S.L. Social class and cardiovascular disease. Behavioral Medicine Approaches to Cardiovascular Disease Prevention 1996, 43-50. Erlbaum, Mahwah, NJ. K. Orth-Gomer, N. Schneiderman (Eds.).
59. Szeto A., McCabe P.M., Nation D.A., Tabak B.A., Rossetti M.A., McCullough M.E., Schneiderman N., Mendez A.J. Evaluation of enzyme immunoassay and radioimmunoassay methods for the measurement of plasma oxytocin. Psychosom. Med. 2011, 73:393-400.
60. Szeto A., Nation D.A., Mendez A.J., Dominguez-Bendala J., Brooks L.G., Schneiderman N., McCabe P.M. Oxytocin attenuates NADPH-dependent superoxide activity and IL-6 secretion in macrophages and vascular cells. Am. J. Physiol. Endocrinol. Metab. 2008, 295:E1495-E1501.
61. Taylor S.E., Gonzaga G.C., Klein L.C., Hu P., Greendale G.A., Seeman T.E. Relation of oxytocin to psychological stress responses and hypothalamic-pituitary-adrenocortical axis activity in older women. Psychosom. Med. 2006, 68:238-245.
62. Taylor S.E., Saphire-Bernstein S., Seeman T.E. Are plasma oxytocin in women and plasma vasopressin in men biomarkers of distressed pair-bond relationships?. Psychol. Sci. 2010, 21:3-7.
63. Tom N., Assinder S.J. Oxytocin in health and disease. Int. J. Biochem. Cell Biol. 2010, 42:202-205.
64. Uvnas-Moberg K. Physiological and endocrine effects of social contact. Ann. N.Y. Acad. Sci. 1997, 807:146-163.
65. Uvnas-Moberg K. Oxytocin may mediate the benefits of positive social interaction and emotions. Psychoneuroendocrinology 1998, 23:819-835.
66. VanderLaan P.A., Reardon C.A., Getz G.S. Site specificity of atherosclerosis: site-selective responses to atherosclerotic modulators. Arterioscler. Thromb. Vasc. Biol. 2004, 24:12-22.
67. Yudkin J.S. Adipose tissue, insulin action and vascular disease: inflammatory signals. Int. J. Obes. Relat. Metab. Disord.: J. Int. Assoc. Study Obes. 2003, 27(Suppl. 3):S25-S28.
68. Yudkin J.S., Kumari M., Humphries S.E., Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?. Atherosclerosis 2000, 148:209-214.
69. Zhou Y., Wei Y., Wang L., Wang X., Du X., Sun Z., Dong N., Chen X. Decreased adiponectin and increased inflammation expression in epicardial adipose tissue in coronary artery disease. Cardiovasc. Diabetol. 2011, 10:2.